CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 111 filers reported holding CLOVIS ONCOLOGY INC in Q4 2013. The put-call ratio across all filers is 0.91 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $131,000 | +23.6% | 2,333 | 0.0% | 0.03% | +30.0% |
| Q3 2014 | $106,000 | +9.3% | 2,333 | 0.0% | 0.02% | +11.1% |
| Q2 2014 | $97,000 | -40.1% | 2,333 | 0.0% | 0.02% | -40.0% |
| Q1 2014 | $162,000 | +14.9% | 2,333 | 0.0% | 0.03% | +20.0% |
| Q4 2013 | $141,000 | -0.7% | 2,333 | 0.0% | 0.02% | 0.0% |
| Q3 2013 | $142,000 | – | 2,333 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 407,416 | $25,940,177,000 | 18.86% |
| Boxer Capital, LLC | 1,000,000 | $63,670,000 | 13.91% |
| Palo Alto Investors LP | 3,894,963 | $247,992,000 | 11.72% |
| Consonance Capital Management LP | 1,334,467 | $84,966,000 | 8.90% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 150,000 | $9,551,000 | 4.70% |
| Crosspoint Capital Strategies, LLC | 82,761 | $5,269,000 | 4.42% |
| Redmile Group, LLC | 972,696 | $61,932,000 | 4.02% |
| Avoro Capital Advisors LLC | 353,900 | $22,533,000 | 2.88% |
| Ghost Tree Capital, LLC | 200,000 | $12,734,000 | 2.37% |
| Partner Investment Management, L.P. | 21,837 | $1,390,000 | 1.69% |